Publications

Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

 50
Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

Tags:

Previous Article

Parkinson’s disease pathogenesis from G6PD deficiency

Next Article

Treating metabolic diseases with microbes containing peptides

Related Posts

Dynamic allostery drives autocrine and paracrine TGF-b signaling

Dynamic allostery drives autocrine and paracrine TGF-b ...

 34

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T Cell proliferation and anti-tumor immunity in mice

A bispecific CD40 agonistic antibody allowing for antib...

 68

Gastric cancer: from biomarkers to functional precision medicine

Gastric cancer: from biomarkers to functional precision...

 297